Skip to contentP
PROCEPT BioRobotics Corp
P
PRCTPROCEPT BioRobotics Corp Q2 2026 · 10-Q
Revenue$94.50M$94.50M+19.3% vs Q2 2025 Net Income-$26.86M-$26.86MN/M vs Q2 2025 EPS Diluted-$0.47-$0.47N/M vs Q2 2025 Gross Profit$62,379,000+20.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PROCEPT BioRobotics Corp · CIK 1588978 · Engraved from SEC EDGAR
Operating Cash Flowderived-$19,251,000N/M Free Cash Flowderived-$22,204,000N/M Margins · derivedGross margin66.0%+0.7 pt vs Q2 2025
Operating margin-29.0%−1.0 pt vs Q2 2025
Net margin-28.4%−3.7 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 5, 2026 · 36 d after period end